SCHEMBL5255161

SCHEMBL5255161

N#CC1(CNC[C@H]2CCCC[C@@H]2NC(=O)c2cc3ccccc3[nH]2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.44
HTR3A P46098 1/20 0.44
KDM4E B2RXH2 2/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SSTR3 P32745 1/20 0.42
FAAH O00519 1/20 0.42
PYGL P06737 1/20 0.41
PYGM P11217 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
MAPK1 P28482 1/20 0.41
KCNH2 Q12809 2/20 0.40
GHSR Q92847 2/20 0.40
OPRM1 P35372 1/20 0.40
DRD2 P14416 3/20 0.40
DRD3 P35462 3/20 0.40
CNR2 P34972 1/20 0.40
CCKBR P32239 3/20 0.39
CCKAR P32238 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5254546 0.89 MLLT1 (0.41) PYGLCCKBRCCKAR
SCHEMBL5257170 0.88 MLLT1 (0.40) PYGLPYGMCNR2CCKBRCCKAR
SCHEMBL5257319 0.88 F10 (0.47) PYGLPYGM
SCHEMBL5254513 0.88 MLLT1 (0.54) KDM4EHPGDHSD17B10PYGLPYGM
SCHEMBL5259530 0.88 PYGL (0.51) PYGL
SCHEMBL5258723 0.87 KDM4E (0.43) KDM4EHPGDPYGLPYGM
SCHEMBL5255587 0.86 F10 (0.35) CHRNA7HTR3AKDM4EHPGDPYGL
SCHEMBL5257371 0.85 MLLT1 (0.38) PYGLGHSR
SCHEMBL5261814 0.84 KMT2A (0.47) KDM4E
SCHEMBL5260311 0.81 SRD5A1 (0.51) KDM4EHPGDHSD17B10PYGLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453801-B1 SUBSTITUTED 2-AMINO-CYCLOALKANECARBOXAMIDES AND THEIR USE AS CYSTEINE PROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2007-03-21 EP disclosed